ALNY vs HLMN · P/E 76, rev $1.29B vs P/E 41, rev $812.3M
Alnylam Pharmaceuticals Inc (ALNY) versus Hillman Solutions Corp (HLMN) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Hillman Solutions Corp (HLMN) is a tools & accessories company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported HLMN revenue for 2026-06-27 was $812.3M. Net income was $16.4M. HLMN currently screens at market cap $1.43B and trailing P/E 40.6.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. HLMN currently screens at market cap $1.43B and trailing P/E 40.6.
Not investment advice. Open the ALNY and HLMN stock pages for the full models.
Not investment advice.